Skip to main content
FranchiseVerdict

Compare

2 brands side-by-side

Compare up to 5 brands side by side

indicates the clear winner per row. Ties and missing data are not highlighted.

How winners are chosen

Lower is better for investment, liquid capital, franchise fee, royalty and ad-fund rates, SBA charge-off rate, and owner turnover.

Higher is better for disclosed revenue and owner earnings, verdict score, total units, net unit growth, and franchisee contacts. For the letter grade, A ranks highest.

A row is highlighted only when one brand clearly leads. Ties are never highlighted, and missing data never counts as a win. Some rows (earnings-metric type, loan counts, contract terms) are informational and have no winner.

Download PDF

These figures come from FDDs of different years (2025, 2026). Costs, fees and unit counts change from one filing to the next, so the older column may be out of date.

Focus by buyer type

Brand
Bio-One logoCAverage
Bio-One
Healthcare
2025 FDD
Remove
Complete Mobile Drug Testing logoCAverage
Complete Mobile Drug Testing
Healthcare
2026 FDD
Remove
Vitals
FDD filing
2025 FDD
FDD issued May 11, 2026
Investment range
$135K – $221K
$68K – $288K
Liquid capital
$15K – $25K
$5K – $8K
Franchise fee
$60K
$55K
Royalty rate
7.5%
10.0%
Ad fund rate
2.0%
0.0%
Performance
Avg gross sales
$389KOutlet subset
$889KCompany-owned only1 outlet
Median gross sales
Not extracted
$889KCompany-owned only1 outlet
Avg owner earnings
Metric varies by brand. Check type below
Not extracted
$394K
Earnings metric
Not classified
Net Profit
Risk
Rating
CAverage
CAverage
Verdict score
44 / 100
43 / 100
SBA charge-off rate
24.0% (n=74)
Not SBA-matched
SBA loans on record
74
N/A
Scale
Total units
137
1
Net change (latest yr)
+7
0
Signed, not yet open
4 (0.03 per open outlet)
Not extracted
Turnover rate
11.7%
0.0%
Contract
Initial term (years)
10
10
Renewal term (years)
10
5
Initial training (hrs)
40
36
Contacts
Franchisee phones
21
1

Need franchisee contacts for these brands?

Save with a contact bundle →